Alphabet disclosed in a filing with the U.S. SEC that, as of the end of September 2026, it held approximately 3 million shares of Qualcomm, valued at about $548 million based on the quarter-end stock price; during the same period, the company fully liquidated its positions in GitLab, Spero Therapeutics, and Autolus Therapeutics.